Evidence map›Paper›PMID 33869074›Full record

ArticleFrontiers in cellular and infection microbiology2021

Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.

Shiju Xiao, Guangzhong Zhang, Chunyan Jiang, Xin Liu, Xiaoxu Wang, Yafan Li, Meijiao Cheng, Hongpeng Lv, Fuyang Xian, Xinwei Guo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions.Frontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Shiju XiaoBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Guangzhong ZhangBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Chunyan JiangBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Xin LiuPuyang Hospital of Traditional Chinese Medicine, Puyang, China.
Xiaoxu WangBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Yafan LiBeijing University of Chinese Medicine, Beijing, China.
Meijiao ChengBeijing QuantiHealth Technology Co., Ltd, Beijing, China.
Hongpeng LvBeijing University of Chinese Medicine, Beijing, China.
Fuyang XianBeijing University of Chinese Medicine, Beijing, China.
Xinwei GuoBeijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Yong TanInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Beijing Hospital of Traditional Chinese Medicine · CNBeijing University of Chinese Medicine · CNCapital Medical University · CNAnyang Hospital of Traditional Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Increasing evidence has shown that alterations in the intestinal microbiota play an important role in the pathogenesis of psoriasis. The existing relevant studies focus on 16S rRNA gene sequencing, but in-depth research on gene functions and comprehensive identification of microbiota is lacking. Objectives: To comprehensively identify characteristic gut microbial compositions, genetic functions and relative metabolites of patients with psoriasis and to reveal the potential pathogenesis of psoriasis. Methods: DNA was extracted from the faecal microbiota of 30 psoriatic patients and 15 healthy subjects, and metagenomics sequencing and bioinformatic analyses were performed. The Kyoto Encyclopedia of Genes and Genomes (KEGG) database, cluster of orthologous groups (COG) annotations, and metabolic analyses were used to indicate relative target genes and pathways to reveal the pathogenesis of psoriasis. Results: Compared with healthy individuals, the gut microbiota of psoriasis patients displayed an alteration in microbial taxa distribution, but no significant difference in microbial diversity. A distinct gut microbial composition in patients with psoriasis was observed, with an increased abundance of the phyla Conclusions: A clear dysbiosis was displayed in the gut microbiota profile, genetic functions and relative metabolites of psoriasis patients. This study is beneficial for further understanding the inflammatory pathogenesis of psoriasis and could be used to develop microbiome-based predictions and therapeutic approaches.

Indexed as

Gastrointestinal MicrobiomePsoriasisDysbiosisFecesHumansMetagenomicsRNA, Ribosomal, 16SVascular Endothelial Growth Factor ARNA, Ribosomal, 16SVascular Endothelial Growth Factor Agenetic functionsgut microbiotametabolitesmetagenomics sequencingpsoriasis

Identifiers

PMID33869074
PMCPMC8047475
OpenAlexW3141160242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.